Ajanta Pharma has launched anti-dementia Memantine Hydrochloride tablets in the US market.

The company has announced in BSE filing ” the launch of Memantine Hydrochloride tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc.”

It further said that the ” The company has launched it in 2 strengths 5 mg and 10 mg tablets to address different levels of treatment.”

Read EquityPandit’s Technical Analysis on Nifty Pharma